Welcome to VIROBLOG from hVIVO.
With a wealth of medical and scientific knowledge within the hVIVO business, and a vast amount of qualified experience in the development and use of human challenge models, we are now committed to making our VIROBLOG a regular feature of our community outreach with regular opinion led items and commentary on issues affecting the drug development, medical research and respiratory disease subject areas.
Please sign-up to follow our VIROBLOG.
We encourage comments and interaction. And don’t forget to connect with us on our other social media properties. VIROBLOG is purposed for more considered articles and scientific discussion going forward, and our hVIVO Twitter, Facebook, LinkedIn and Google+ communities are available for more regular news updates and “soundbites” from in and around our sector.”
December 18, 2015 9:46 am
Vaxart Announces Enrollment of First Patient in Influenza B Phase 1 Trial | Vaccines | News Channels
December 2, 2015 8:25 am
Motavizumab reduces RSV hospitalizations in Native American infants
November 26, 2015 1:42 pm
Influenza-Associated Excess Mortality in South Korea
November 26, 2015 1:32 pm
Press Announcements > FDA approves first seasonal influenza vaccine containing an adjuvant
November 11, 2015 9:54 am
Sanofi Pasteur shares universal influenza vaccine research | Vaccine News
November 7, 2015 7:54 pm
RSV MUCOSAL VACCINE – KIDO HIROSHI
November 7, 2015 7:52 pm
Palivizumab prophylaxis for respiratory syncytial virus (RSV) in infants with cystic fibrosis (CF) and respiratory illness hospitalizations | European Respiratory Society
November 7, 2015 1:49 pm
WHO | Influenza update
November 7, 2015 11:56 am
VBI Vaccines to Present Update and New Data Supporting its RSV and CMV Vaccine Programs at the World Vaccine Congress Europe – NASDAQ.com
November 2, 2015 10:36 am